Career history of Daniel Dolan
Former positions of Daniel Dolan
| Companies | Position | Start | End |
|---|---|---|---|
| NABRIVA THERAPEUTICS PLC | Director of Finance/CFO | 11/03/2021 | 29/06/2023 |
| RADIUS HEALTH, INC. | Comptroller/Controller/Auditor | 23/09/2020 | 14/12/2020 |
| Director of Finance/CFO | 23/09/2020 | 14/12/2020 | |
| Corporate Officer/Principal | 14/12/2020 | 14/01/2021 | |
| Treasurer | 23/09/2020 | 14/12/2020 | |
| SHIRE | Corporate Officer/Principal | 31/08/2005 | 30/06/2017 |
Training of Daniel Dolan
| Widener University | Masters Business Admin |
Statistics
International
| United States | 3 |
| Ireland | 3 |
Operational
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Private companies | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Daniel Dolan
- Experience